May 17, 2024
Life Sciences | Tea Leaves
  • The U.S. Justice Department on Thursday unveiled a historic proposal to ease restrictions on marijuana, a rule that, if enacted, would also enable more research on its medicinal benefits. The proposal, first announced in April, would reclassify cannabis from a so-called schedule one drug to a schedule three. Schedule one drugs, such as heroin, are considered highly addictive with no medical benefits, while schedule three drugs are considered to have a moderate to low potential for physical and psychological dependence. Marijuana and drug policy experts were underwhelmed by the White House’s aim of rescheduling, saying it doesn’t go far enough to address the issues surrounding marijuana’s criminalization. (Articles herehere, and here)